STUDIES ON THE NATURE AND FUNCTION OF THE PHOSPHOPROTEIN, PROSOLIN
磷酸蛋白普罗索林的性质和功能研究
基本信息
- 批准号:3808555
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:DNA replication T lymphocyte cell differentiation cellular oncology cytoskeletal proteins growth inhibitors hematopoietic stem cells human tissue lymphocyte lymphocyte proliferation molecular cloning myelogenous leukemia neoplastic cell nucleic acid sequence phosphoproteins phosphorylation protein biosynthesis protein kinase protein sequence protein structure function tissue /cell culture
项目摘要
We have continued our studies on the cytosolic phosphoprotein, Prosolin,
which was discovered in this laboratory. It is a major cytosolic protein
of proliferating human lymphocytes and promyelocytic cells, but is not
expressed in resting peripheral blood lymphocytes. We found that
prosolin is an important early target of the activities associated with
T-cell receptor (TCr) activation, indicating that prosolin
phosphorylation serves to transmit the signal generated by TCr occupancy
in the proliferating normal lymphocyte. Prosolin phosphorylation induced
by TCr activation or by other treatments is invariably followed by rapid,
but temporary, down regulation of DNA synthesis in normal proliferating
lymphocytes. This may represent a normal regulatory aspect of the immune
system. The rapid phosphorylation of prosolin that follows TCr
activation is complex, resulting in 4 phosphorylated forms of the
molecule containing variable numbers of phosphorylated serine residues.
Evidence suggests that more than one protein kinase is involved in this
complex phosphorylation event, and that one of these activities may be
deficient in T-cell leukemia cells with the result that some of the
phosphorylated forms of prosolin do not appear in such cells. We have
cloned and sequenced the prosolin cDNA from normal human peripheral blood
lymphocytes and have identified various potential phosphorylation sites.
我们继续对胞浆磷蛋白Prosolin进行研究,
它是在这个实验室里发现的。它是一种主要的胞质蛋白
增殖的人类淋巴细胞和早幼粒细胞,但不是
在静息状态的外周血淋巴细胞中表达。我们发现
Prosolin是与以下相关的活动的重要早期靶点
T细胞受体(TCR)激活,表明前列腺素
磷酸化用于传递TCR占用产生的信号
在增殖的正常淋巴细胞中。Prosolin诱导的磷酸化
通过TCR激活或通过其他处理总是紧跟着快速,
但在正常增殖中,DNA合成的暂时性下调
淋巴细胞。这可能代表了免疫的正常调节方面。
系统。前列腺素在TCR之后的快速磷酸化
激活是复杂的,导致4种磷酸化形式的
含有数量可变的磷酸化丝氨酸残基的分子。
有证据表明不止一种蛋白激酶参与了这一过程。
复杂的磷酸化事件,并且这些活性之一可能是
缺乏T细胞白血病细胞,结果是一些
磷酸化形式的前列腺素不会出现在这样的细胞中。我们有
正常人外周血中前列腺素基因的克隆及序列分析
并已确定了各种潜在的磷酸化位点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H L COOPER其他文献
H L COOPER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H L COOPER', 18)}}的其他基金
CYTOSKELETAL PROTEINS IN ONCOGENIC TRANSFORMATION AND HUMAN NEOPLASIA
致癌转化和人类肿瘤中的细胞骨架蛋白
- 批准号:
3813406 - 财政年份:
- 资助金额:
-- - 项目类别:
CYTOSKELETAL PROTEINS IN ONCOGENE TRANSFORMATION AND HUMAN NEOPLASIA
癌基因转化和人类肿瘤中的细胞骨架蛋白
- 批准号:
3774355 - 财政年份:
- 资助金额:
-- - 项目类别:
BIOCHEMICAL EVENTS IN PHORBOL ESTER EFFECTS ON NORMAL AND TUMOR CELLS
佛波酯对正常细胞和肿瘤细胞影响的生化事件
- 批准号:
4691884 - 财政年份:
- 资助金额:
-- - 项目类别:
CYTOSKELETAL PROTEINS IN ONCOGENIC TRANSFORMATION AND HUMAN NEOPLASIA
致癌转化和人类肿瘤中的细胞骨架蛋白
- 批准号:
3808560 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES ON THE NATURE AND FUNCTION OF THE PHOSPHOPROTEIN, PROSOLIN
磷酸蛋白普罗索林的性质和功能研究
- 批准号:
3939334 - 财政年份:
- 资助金额:
-- - 项目类别:
BIOCHEMICAL EVENTS IN PHORBOL ESTER EFFECTS ON NORMAL AND TUMOR CELLS
佛波酯对正常细胞和肿瘤细胞影响的生化事件
- 批准号:
3963055 - 财政年份:
- 资助金额:
-- - 项目类别:
CYTOSKELETAL PROTEINS IN ONCOGENIC TRANSFORMATION AND HUMAN NEOPLASIA
致癌转化和人类肿瘤中的细胞骨架蛋白
- 批准号:
3916370 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual